Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PepGen Inc. - Common Stock
(NQ:
PEPG
)
2.370
-0.030 (-1.25%)
Delayed Quote
Updated: 1:53 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 06, 2026
From
PepGen Inc.
Via
Business Wire
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
August 06, 2026
From
PepGen Inc.
Via
Business Wire
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
May 21, 2026
From
PepGen Inc.
Via
Business Wire
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
From
PepGen Inc.
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 28, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 21, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 14, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
April 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
March 31, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
March 31, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Tuesday?
↗
March 31, 2026
Via
Chartmill
The market is filled with gapping stocks in Tuesday's session.
↗
March 31, 2026
Via
Chartmill
Discover the top movers in Tuesday's pre-market session.
↗
March 31, 2026
Via
Chartmill
Monday's after hours session: top gainers and losers
↗
March 30, 2026
Via
Chartmill
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
March 30, 2026
From
PepGen Inc.
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
March 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
March 17, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
March 05, 2026
Via
Chartmill
Get insights into the top gainers and losers of Wednesday's after-hours session.
↗
March 04, 2026
Via
Chartmill
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
March 04, 2026
From
PepGen Inc.
Via
Business Wire
PepGen Announces Regulatory Updates on FREEDOM2
March 04, 2026
From
PepGen Inc.
Via
Business Wire
PepGen to Participate in the Leerink Global Healthcare Conference
March 03, 2026
From
PepGen Inc.
Via
Business Wire
What's going on in today's pre-market session
↗
January 02, 2026
Via
Chartmill
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
December 09, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
December 08, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
November 12, 2025
From
PepGen Inc.
Via
Business Wire
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 12, 2025
From
PepGen Inc.
Via
Business Wire
PepGen to Participate in Upcoming Investor Conferences
November 03, 2025
From
PepGen Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 27, 2025
Via
Benzinga
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 13, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
